Predictor | Univariate analysis | ||||
---|---|---|---|---|---|
B | SE | Wald | Sig. | OR (95% CI) | |
Demographic criteria | |||||
• Age (years) | 0.054 | 0.020 | 7.217 | 0.007 | 1.055 (1.015–1.097) |
• Sex (male) | − 0.001 | 0.284 | 0.000 | 0.996 | 0.999 (0.573–1.741) |
Pre-intervention reserve liver functions | |||||
• ALT (IU/L) | 0.027 | 0.015 | 3.540 | 0.060 | 1.028 (0.999–1.057) |
• AST (IU/L) | 0.025 | 0.013 | 3.573 | 0.059 | 1.025 (0.999–1.052) |
• s.albumin (gm/dl) | − 6.388 | 0.909 | 49.331 | 0.000 | 0.002 (0.000–0.010) |
• s.bilirubin (mg/dl) | 3.122 | 0.694 | 20.254 | 0.000 | 22.692 (5.826–88.381) |
• PC (%) | − 0.178 | 0.036 | 23.891 | 0.000 | 0.837 (0.779–0.899) |
Pre-interventional liver volumetric measures | |||||
• Liver volume (LV) (cm3) | 0.000 | 0.000 | 1.565 | 0.211 | 1.000 (1.000–1.001) |
• Tumor volume (TV) (cm3) | 0.002 | 0.000 | 26.546 | 0.000 | 1.002 (1.001–1.0023) |
• Residual volume (RV) (cm3) | − 0.001 | 0.000 | 9.287 | 0.002 | 0.999 (0.998–0.999) |
• Residual to liver volumetric ratio (RLVR) | − 8.514 | 1.402 | 36.861 | 0.000 | 0.000 (0.000–0.003) |
Other evaluated clinical and laboratory parameters | |||||
• Spleen diameter (cm) | 0.106 | 0.058 | 3.314 | 0.069 | 1.111 (0.992–1.245) |
• s.creatinine (mg/dl) | − 0.953 | 1.008 | 0.894 | 0.345 | 0.386 (0.054–2.780) |
• Platelets (× 103/mm3) | − 0.006 | 0.004 | 2.384 | 0.123 | 0.994 (90.987–1.002) |
• AFP (ng/ml) | 0.001 | 0.001 | 3.592 | 0.058 | 1.001 (1.000–1.002) |
• Child-Pugh score | 1.536 | 0.232 | 43.663 | 0.000 | 4.646 (2.946–7.358) |